ERBB3 (Erb-b2 receptor tyrosine kinase 3), as a member of the ErbB family, is highly expressed in a variety of common tumors and can induce resistance to a variety of tumor therapeutic drugs when activated [21, 22]. Here, EGFR is linked to neoplasm.